Established in 1997, Peptron focuses on platform technology and clinical developments. Referred to as "Cozy-Cure," Peptron's highest priority is promoting and promising the best quality of life for patients with better treatment options, compliance, and price advantage.
Peptron members' expertise in drug discovery and research, business development and strategic planning, drug delivery and formulation, GMP production, and Quality Control has helped develop peptide-based platform technology, SmartDepot™.
SmartDepot™ brings the initial research process to the final medication development and successful commercialization phase with superior competitiveness. In line with proprietary technologies, we develop sustained-release (SR) medications to extend the release profile of the drug from weekly to monthly.
Further, Peptron values global CDMO business. In the last few years, we have successfully formulated working with global companies with our in-depth expertise and resources. Peptron can work with you to achieve formulation development, regulatory approval and commercial manufacturing.
Contact us: biz@peptron.co.kr
Company Details
- Employees
- 16
- Founded
- -
- Address
- 37-24, Yuseong-Daero 1628 Beon-Gil, Yuseong-Gu, Daejeon,34054,korea, Republic Of
- Industry
- Biotechnology
- Website
- http://www.peptron.com
- Keywords
- controlled-release formulation development, microsphere formulation, CDMO, drug delivery system.
- HQ
- Daejeon
Peptron, Inc. Questions
Peptron, Inc.'s website is http://www.peptron.com
Peptron, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/peptroncozycure
Peptron, Inc. has
16 employees.
View email and phone details for 16
employees at Peptron, Inc..
Peptron, Inc.'s industry is
Biotechnology
Peptron, Inc.'s top competitors are
Cha Healthcare,
Tct Saglik,
리가켐바이오,
Alteogen,
Livespo,
G2gbio,
Proteina,
Transvuc Transportes De Cargas,
Adalta Ltd,
Abl Bio Inc..
Peptron, Inc.'s categories are Biotechnology
Peptron, Inc.'s founding year is 1997
